pyridinolcarbamate has been researched along with Focal Segmental Glomerulosclerosis in 1 studies
Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Oppermann, W | 1 |
| Reddi, AS | 1 |
| Velasco, CA | 1 |
| Davalos, RA | 1 |
1 other study available for pyridinolcarbamate and Focal Segmental Glomerulosclerosis
| Article | Year |
|---|---|
Attempts to delay the progression of inherited vasculopathy.
Topics: Animals; Basement Membrane; Glomerulosclerosis, Focal Segmental; Glucose Tolerance Test; Glycoprotei | 1976 |